Viimane versioon :
Ravimite stabiilsus ja sobivus
Teretulemast Stabilise võrgulehele. Kui soovite kvartaliväljaannet, lisage oma e-posti aadress. Registreeri

Küsimuste ja kommentaaride korral palun kontakteeruda
Viited : 2758
Ingredient : 856
Ingrediendi farmakoloogiline grupp : 46
Lahuste stabiilsus : 6324
Stabiilsus segudes : 1245
Sobimatus : 12364
Kaubanduslik nimi : 5053
Uudised - Ingredient  
Mitmesugune Süsteravim Disodium glucose-1-phosphate tetrahydrate 18/01/2024
Viirusevastane ravim Süsteravim Remdesivir 13/09/2023
Neuroleptikum Suukaudne lahus Lurasidone 28/08/2023
Mitmesugune Kapsel Cholic acid 12/06/2023
Mitmesugune Suukaudne lahus L-Methionine 22/05/2023
üldanesteetikum Ravimküünal Pentobarbital 22/05/2023
Antibiootikum Kapsel Erythromycine 22/05/2023
Viirusevastane ravim Silmatilgad Ganciclovir 02/03/2023
Anksiolüütiline ravim Süsteravim Remimazolam 28/02/2023
Mitmesugune Süsteravim Teduglutide 24/02/2023
Mitmesugune Salv Resorcinol 19/01/2023
Antihüpertensiivne ravim Kapsel Clonidine hydrochloride 05/12/2022
Antibiootikum Süsteravim Omadacycline 20/11/2022
Vähiravimite Süsteravim Trastuzumab deruxtecan 17/11/2022
Vähiravimite Suukaudne lahus Vinorelbine 05/11/2022
Antibiootikum Süsteravim Cefradine 06/09/2022
Mitmesugune Süsteravim Ambroxol 06/09/2022
üldanesteetikum Süsteravim Esketamine 01/09/2022
Vähiravimite Süsteravim Melphalan captisol 01/09/2022
Antibiootikum Süsteravim Mezlocilline 01/09/2022
Uudised - Viited  
4802 Glucose-1-Phosphate disodique tétrahydraté (Phocytan®) - Résumé des caractéristiques du produit Aguettant Laboratory 18/01/2024
4786 Etude de stabilité de solutions de pembrolizumab à 1 et 4 mg/mL à 5 et 25°C dans des poches de NaCl 0,9% en polyoléfine . SFPO Congress 07/11/2023
4784 In-use stability of ready-to- administer daratumumab subcutaneous injection solution in plastic syringes. EJHP 04/11/2023
4785 Darzalex 1800 mg solution for injection - Summary of Product characteristics. Janssen-Cilag International NV 04/11/2023
4782 In‑Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period. Drugs R D 07/10/2023
4780 Extemporaneous Topical Minoxidil Solutions for the treatment of Alopecia : Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base. Int J Pharm Compound 13/09/2023
4776 Antiemetic Drugs Compatibility Evaluation with Paediatric Parenteral Nutrition Admixtures. Pharmaceutics 08/09/2023
4777 Physicochemical and microbiological stability of azathioprine suspensions in PCCA base Suspendit. Int J Pharm Compound 08/09/2023
4778 Chemical stability of epinephrine 10 µg/mL doluted in 0.9% sodium chloride and stored in polypropylene syringes at 4°C and 25°C. Int J Pharm Compound 08/09/2023
4773 Predictive stability, novel HPLC-MS analysis and semi-automatic compounding process for the emergency implementation of a production line of pancuronium in injectable solution. Eur J Pharm Sci 03/09/2023
4770 Use of a liquid chromatography-tandem mass spectrometry method to assess the concentration of epinephrine, norepinephrine, and phenylephrine stored in plastic syringes. Pharmaceutical Technology in Hospital Pharmacy 22/08/2023
4772 Stability of Opened Durvalumab (IMFINZI) Vials. The Beginning of the End of Costly Product Wastage? J Pharm Sci 22/08/2023
4767 Physicochemical stability of durvalumab (Imfinzi® ) concentrate for solution in original vials after first opening. Pharmaceutical Technology in Hospital Pharmacy 02/08/2023
4763 Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL) Pharmaceutical Technology in Hospital Pharmacy 02/08/2023
4766 Stability of omeprazole extemporaneous oral solution in Chopin Base. Int J Pharm Compound 02/08/2023
4768 Y-site injection physical compatibility of remdesivr with select intravenous drugs used in palliative care and for treating coronavirus disease 2019. Journal of Nippon Medical school 02/08/2023
4769 Cisatracurium Besylate 10 mg/mL Solution Compounded in a Hospital Pharmacy to Prevent Drug Shortages : A Stability Study Involving Four Degradation Products. Pharmaceutics 02/08/2023
4762 Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature EJHP 01/08/2023
4761 Physicochemical stability of Cabazitaxel Zentiva® solution in vials after opening and diluted- solutions in three infusion bags. Pharmaceutical Technology in Hospital Pharmacy 28/07/2023
4758 Stability Study and Simultaneous Determination of Norepinephrine, Moxifloxacin, and Piperacillin + Tazobactam Mixtures Applied in Intensive Care Medicine . Curr Pharm Anal 10/07/2023
4759 Stability of 5-fluorouracil at 4°C, 25°C, and 33°C stored in NiproSureFuser+ Ambulatory Balloon Infusers. Sunnybrook Healt Science Centre 10/07/2023
4757 In Vitro Assessment of Compounded Lurasidone Suspensions for Enteral Feeding Tubes. Hosp Pharm 06/06/2023
4756 Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions. J Oncol Pharm Practice 16/05/2023
4755 Extended physicochemical stability of cetuximab in opened vials and infusion bags when stored at 4°C and 25°C. J Oncol Pharm Practice 03/05/2023
4754 Physicochemical stability of PF-05280014 (trastuzumab-qyyp; TrazimeraTM), a trastuzumab biosimilar, under extended in-use conditions. J Oncol Pharm Practice 26/04/2023
4747 Pharmaceutical Oral Formulation of Methionine as a Pediatric Treatment in Inherited Metabolic Disease. Pharmaceutics 24/04/2023
4748 Physicochemical Stability of Generic Thiotepa Concentrate and Ready-to-Administer Infusion Solutions for Conditioning Treatment. Pharmaceutics 24/04/2023
4750 Development and Stability of a New Formulation of Pentobarbital Suppositories for Paediatric Procedural Sedation. Pharmaceutics 24/04/2023
4751 Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects. Pharmaceutics 24/04/2023
4746 Stability and Compatibility of Bupivacaine and Hydromorphone in PVC and non-DEHP bags for 30 days at 4°C and 25°C. 14/04/2023

  Mentions Légales